Email Newsletters

Life Sciences

Acquisitions Are A Way Of Life For Boston Scientific

In March, Natick medical device maker Boston Scientific (BSX)announced it would acquire implantable defibrillator company Cameron Health...

PerkinElmer Aims For Health Care Innovation In Hopkinton

Waltham-based PerkinElmer Inc. said it plans to establish a new research center at its recently acquired Caliper...

FDA Approves Additional BSX Stent Sizes

Natick-based Boston Scientific Corp. announced it has received regulatory approval from the U.S. Food and Drug Administration...

Boston Scientific Product Clears FDA Hurdle

Natick-based Boston Scientific said the U.S. Food and Drug Administration has approved expanded use of a product...
ADVERTISEMENT

Repeal The Tax On Medical Devices

In 2009, as the Patient Protection & Affordable Care Act was taking shape, two schools of thought...

State Reaches Settlements With Abbott

Abbott Laboratories, which has a bioresearch facility in Worcester, has reached agreement with Massachusetts and other states...

ACT Gets First European Stem Cell OK

Advanced Cell Technology Inc. of Marlborough said it has received clearance for a U.K. clinical trial involving human...

ACT Gets Patent For Blood Cell Tech

Marlborough-based Advanced Cell Technology Inc. has received a patent for a method of creating various blood cells...
ADVERTISEMENT

Caliper Purchase Has Analysts Optimistic

The proposed sale of Caliper Life Sciences to Waltham-based advanced technologies firm PerkinElmer Inc. could create mutually...

Genzyme Restructures Drug Deal

Genzyme announced that it has restructured its collaboration with New Jersey-based PTC Therapeutics on an investigational drug.Under...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA